1. From the Cardiovasular Epidemiology Research Group (E.Z., G.E., H.P.-R.), Department of Neurology (E.Z., H.P.-R.), and Department of Coagulation Disorders (P.J.S.), Malmö University Hospital, Institution of Clinical Sciences in Malmö, University of Lund, Lund, Sweden; Astra Zeneca R&D (G.E.), Lund, Sweden; and the Department of Neurology (B.N.), Lund University Hospital, Lund, Sweden.